Blood Banking Assessment Exam 2026/2027
BLOOD BANKING ASSESSMENT EXAM
2026/2027 Academic Year
────────────────────────────────────────
Comprehensive Immunohematology, Transfusion Medicine
& Laboratory Competency Assessment
AABB Standards / ASCP Board of Certification
Total Questions: 75 Multiple-Choice Questions (MCQ)
Testing Time: 120 Minutes (Computer-Based, Proctored)
Passing Score: 75–80% (56–60/75 Correct)
Item Types: Standard MCQ, SATA, Serology Vignettes, Component Scenarios, Reaction Investigation,
Regulatory Compliance
Format: Single-Best-Answer Unless Marked SATA
1
, Blood Banking Assessment Exam 2026/2027
Examination Overview
Domain Questions Key Topics Weight
ABO/Rh Blood Group 12 ABO 16%
Systems & Antigens/Antibodies, Rh
Immunohematology System (D/C/E/c/e),
Fundamentals Forward/Reverse Typing,
Discrepancy Resolution
Antibody Screening, 14 Antibody Screens, Panel 19%
Identification & Interpretation, AHG
Compatibility Testing Testing, Crossmatch
Methods,
Auto/Alloantibody
Differentiation
Blood Component 13 RBCs/Platelets/FFP/Cryo 17%
Therapy & Transfusion Indications, Storage
Practice Requirements, Dosing,
Special Products
(Irradiated/CMV-
Neg/Washed)
Transfusion Reactions 11 Acute/Delayed 15%
& Adverse Events Hemolytic, Febrile Non-
Hemolytic, Allergic,
TRALI, TACO,
Investigation Protocols
Donor Eligibility, 10 Donor Criteria, Deferral 13%
Collection & Reasons, Apheresis,
Component Component Processing,
Preparation Labeling Requirements
Quality Control, 9 AABB/FDA/CAP 12%
Regulatory Compliance Standards, QC
& Laboratory Safety Procedures, Error
Management, Biosafety,
Documentation
Special Populations & 6 Pediatric/Neonatal 8%
Clinical Scenarios Transfusion, Massive
Transfusion,
Autoimmune Hemolytic
Anemia, Sickle Cell
Disease
Domain: ABO/Rh Blood Group Systems & Immunohematology Fundamentals
──────────────────────────────────────────────────────────────────
──────────────
1. A patient's forward typing shows agglutination with anti-A and anti-B reagents, but
reverse typing shows no agglutination with A1 or B reagent cells. What is the most likely
explanation for this ABO discrepancy?
A. The patient is a newborn with immature antibody production
B. The patient has acquired B antigen due to bacterial infection
C. The patient is group AB with weak subgroups
D. The patient has cold agglutinins interfering with testing
Correct Answer: A
2
, Blood Banking Assessment Exam 2026/2027
Rationale: Newborns and infants under 4-6 months of age often lack detectable anti-A and anti-B
antibodies in reverse typing because isoagglutinin production matures after birth. Forward typing (cell
typing) detects antigens on patient RBCs and is reliable at birth; reverse typing (serum typing) detects
naturally occurring antibodies and may be negative in infants. This is the most common cause of ABO
discrepancy in pediatric patients. Acquired B (B) typically causes weak reaction with anti-B in forward
typing. Weak subgroups (C) would show weak/missing forward reactions. Cold agglutinins (D)
typically cause pan-agglutination at room temperature, not isolated reverse typing discrepancies.
2. Which Rh antigen is considered the most immunogenic after D?
A. C
B. c
C. E
D. e
Correct Answer: C
Rationale: After the D antigen, the E antigen is the most immunogenic Rh antigen, followed by c, C, and
e. Immunogenicity refers to the likelihood of stimulating antibody production following exposure in a
sensitized individual. This hierarchy guides Rh prophylaxis and component selection for patients with
Rh antibodies. Understanding relative immunogenicity is essential for preventing alloimmunization in
transfusion-dependent patients and managing pregnant patients at risk for hemolytic disease of the
fetus and newborn (HDFN).
3. A patient with blood group O requires an emergency transfusion before complete typing
is available. Which RBC component is most appropriate to issue?
A. Group O, Rh-negative RBCs
B. Group O, Rh-positive RBCs
C. Group AB, Rh-negative RBCs
D. Group A, Rh-negative RBCs
Correct Answer: A
Rationale: In emergency release situations before complete typing, group O, Rh-negative RBCs are the
universal donor product for RBC transfusion because they lack A, B, and D antigens, minimizing risk of
hemolytic reaction in recipients of any ABO/Rh type. Group O Rh-positive (B) carries risk of anti-D
sensitization in Rh-negative recipients, particularly females of childbearing potential. Group AB (C)
contains A and B antigens and would cause hemolysis in non-AB recipients. Group A (D) contains A
antigen and would hemolyze in group O or B recipients. Once patient type is confirmed, type-specific
blood should be substituted.
4. Select All That Apply: Which of the following are characteristics of naturally occurring
ABO antibodies?
A. Primarily IgM class
B. React optimally at room temperature or below
C. Do not cross the placenta
D. Are stimulated by exposure to environmental antigens (e.g., bacteria, food)
Correct Answer: A,B,C,D
Rationale: All statements are correct: ABO antibodies are primarily IgM (A), react best at room
temperature or colder (B), do not cross the placenta due to IgM size (C), and are stimulated by exposure
to environmental antigens with structures similar to A/B antigens (D). These characteristics distinguish
naturally occurring ABO antibodies from immune alloantibodies (e.g., anti-D, anti-K), which are
typically IgG, react at 37°C/AHG, cross the placenta, and require prior sensitization. Understanding
these differences is essential for antibody identification and HDFN risk assessment.
5. A patient's RBCs type as group A, but the serum contains both anti-A and anti-B. What is
the most likely explanation?
A. The patient has acquired B antigen
3
BLOOD BANKING ASSESSMENT EXAM
2026/2027 Academic Year
────────────────────────────────────────
Comprehensive Immunohematology, Transfusion Medicine
& Laboratory Competency Assessment
AABB Standards / ASCP Board of Certification
Total Questions: 75 Multiple-Choice Questions (MCQ)
Testing Time: 120 Minutes (Computer-Based, Proctored)
Passing Score: 75–80% (56–60/75 Correct)
Item Types: Standard MCQ, SATA, Serology Vignettes, Component Scenarios, Reaction Investigation,
Regulatory Compliance
Format: Single-Best-Answer Unless Marked SATA
1
, Blood Banking Assessment Exam 2026/2027
Examination Overview
Domain Questions Key Topics Weight
ABO/Rh Blood Group 12 ABO 16%
Systems & Antigens/Antibodies, Rh
Immunohematology System (D/C/E/c/e),
Fundamentals Forward/Reverse Typing,
Discrepancy Resolution
Antibody Screening, 14 Antibody Screens, Panel 19%
Identification & Interpretation, AHG
Compatibility Testing Testing, Crossmatch
Methods,
Auto/Alloantibody
Differentiation
Blood Component 13 RBCs/Platelets/FFP/Cryo 17%
Therapy & Transfusion Indications, Storage
Practice Requirements, Dosing,
Special Products
(Irradiated/CMV-
Neg/Washed)
Transfusion Reactions 11 Acute/Delayed 15%
& Adverse Events Hemolytic, Febrile Non-
Hemolytic, Allergic,
TRALI, TACO,
Investigation Protocols
Donor Eligibility, 10 Donor Criteria, Deferral 13%
Collection & Reasons, Apheresis,
Component Component Processing,
Preparation Labeling Requirements
Quality Control, 9 AABB/FDA/CAP 12%
Regulatory Compliance Standards, QC
& Laboratory Safety Procedures, Error
Management, Biosafety,
Documentation
Special Populations & 6 Pediatric/Neonatal 8%
Clinical Scenarios Transfusion, Massive
Transfusion,
Autoimmune Hemolytic
Anemia, Sickle Cell
Disease
Domain: ABO/Rh Blood Group Systems & Immunohematology Fundamentals
──────────────────────────────────────────────────────────────────
──────────────
1. A patient's forward typing shows agglutination with anti-A and anti-B reagents, but
reverse typing shows no agglutination with A1 or B reagent cells. What is the most likely
explanation for this ABO discrepancy?
A. The patient is a newborn with immature antibody production
B. The patient has acquired B antigen due to bacterial infection
C. The patient is group AB with weak subgroups
D. The patient has cold agglutinins interfering with testing
Correct Answer: A
2
, Blood Banking Assessment Exam 2026/2027
Rationale: Newborns and infants under 4-6 months of age often lack detectable anti-A and anti-B
antibodies in reverse typing because isoagglutinin production matures after birth. Forward typing (cell
typing) detects antigens on patient RBCs and is reliable at birth; reverse typing (serum typing) detects
naturally occurring antibodies and may be negative in infants. This is the most common cause of ABO
discrepancy in pediatric patients. Acquired B (B) typically causes weak reaction with anti-B in forward
typing. Weak subgroups (C) would show weak/missing forward reactions. Cold agglutinins (D)
typically cause pan-agglutination at room temperature, not isolated reverse typing discrepancies.
2. Which Rh antigen is considered the most immunogenic after D?
A. C
B. c
C. E
D. e
Correct Answer: C
Rationale: After the D antigen, the E antigen is the most immunogenic Rh antigen, followed by c, C, and
e. Immunogenicity refers to the likelihood of stimulating antibody production following exposure in a
sensitized individual. This hierarchy guides Rh prophylaxis and component selection for patients with
Rh antibodies. Understanding relative immunogenicity is essential for preventing alloimmunization in
transfusion-dependent patients and managing pregnant patients at risk for hemolytic disease of the
fetus and newborn (HDFN).
3. A patient with blood group O requires an emergency transfusion before complete typing
is available. Which RBC component is most appropriate to issue?
A. Group O, Rh-negative RBCs
B. Group O, Rh-positive RBCs
C. Group AB, Rh-negative RBCs
D. Group A, Rh-negative RBCs
Correct Answer: A
Rationale: In emergency release situations before complete typing, group O, Rh-negative RBCs are the
universal donor product for RBC transfusion because they lack A, B, and D antigens, minimizing risk of
hemolytic reaction in recipients of any ABO/Rh type. Group O Rh-positive (B) carries risk of anti-D
sensitization in Rh-negative recipients, particularly females of childbearing potential. Group AB (C)
contains A and B antigens and would cause hemolysis in non-AB recipients. Group A (D) contains A
antigen and would hemolyze in group O or B recipients. Once patient type is confirmed, type-specific
blood should be substituted.
4. Select All That Apply: Which of the following are characteristics of naturally occurring
ABO antibodies?
A. Primarily IgM class
B. React optimally at room temperature or below
C. Do not cross the placenta
D. Are stimulated by exposure to environmental antigens (e.g., bacteria, food)
Correct Answer: A,B,C,D
Rationale: All statements are correct: ABO antibodies are primarily IgM (A), react best at room
temperature or colder (B), do not cross the placenta due to IgM size (C), and are stimulated by exposure
to environmental antigens with structures similar to A/B antigens (D). These characteristics distinguish
naturally occurring ABO antibodies from immune alloantibodies (e.g., anti-D, anti-K), which are
typically IgG, react at 37°C/AHG, cross the placenta, and require prior sensitization. Understanding
these differences is essential for antibody identification and HDFN risk assessment.
5. A patient's RBCs type as group A, but the serum contains both anti-A and anti-B. What is
the most likely explanation?
A. The patient has acquired B antigen
3
